Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-06-15FDA Approved: AVODART — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for AVODART (dutasteride) submitted by Waylis Therapeutics LLC.
-
FDA approval · 2010-06-14FDA Approved: JALYN — Original Application (Waylis Therapeutics)
FDA approved JALYN, a fixed-dose combination of dutasteride and tamsulosin hydrochloride, from Waylis Therapeutics via an Original Applicati…
-
FDA approval · 2010-06-10FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Finasteride from Aurobindo Pharma Limited under their ANDA. This approves the generic Finasterid…
-
FDA approval · 2010-06-07FDA Approved: FINASTERIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for finasteride, making a generic version of the drug available.
-
FDA approval · 2010-05-27FDA Approved: FINASTERIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for finasteride submitted by Dr. Reddy's Laboratories Limited, updating the regulatory status of thi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-05-26FDA Approved: FINASTERIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's generic finasteride, enabling continued marketing of the product.
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection [Phase 4]
A Phase 4 clinical trial comparing Total Intravenous Anesthesia (TIVA) with Spinal Anesthesia in patients undergoing transurethral resection…
-
CLINICAL_TRIALS trial_result · 2010-04-27Clinical Trial Update: The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months [Phase 3]
Phase 3 trial update reports safety findings for a new drug used for nine months in patients with Benign Prostatic Hyperplasia.
-
FDA approval · 2010-04-27FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved the original application for tamsulosin hydrochloride (generic) from Sandoz Inc, expanding availability of this medication.
-
FDA approval · 2010-04-27FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (EXELAN PHARMACEUTICALS, INC.)
FDA approved an original ANDA for tamsulosin hydrochloride, confirming a generic version of the drug.
-
FDA approval · 2010-04-27FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original ANDA for Tamsulosin Hydrochloride from Zydus Lifesciences Limited. Tamsulosin hydrochloride is a generic alpha-1 b…
-
FDA approval · 2010-04-09FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for UROXATRAL (alfuzosin hydrochloride) from Advanz Pharma (US) Corp.
-
CLINICAL_TRIALS trial_result · 2010-03-30Clinical Trial Update: Benign Prostatic Hyperplasia in Taiwan [NA]
A Sanofi-sponsored clinical trial investigating benign prostatic hyperplasia in Taiwan has completed.
-
FDA approval · 2010-03-23FDA Approved: PROSCAR — Supplemental Application (Organon LLC)
The FDA has approved a supplemental application for PROSCAR (finasteride) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2010-03-16Clinical Trial Update: Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment [Phase 3]
This clinical trial update reports results from a Phase 3 study evaluating a dutasteride and tamsulosin combination for benign prostatic hyp…
-
FDA approval · 2010-03-16FDA Approved: CARDURA XL — Supplemental Application (Viatris Specialty LLC)
FDA approves a supplemental application for Cardura XL (doxazosin mesylate) by Viatris Specialty LLC to modify or expand the labeling.
-
CLINICAL_TRIALS trial_result · 2010-03-15Clinical Trial Update: Transurethral Ventral Wall of Urethra-preserving Enucleation of Prostate [NA]
This document provides an update on a clinical trial evaluating a surgical technique for benign prostatic hyperplasia—transurethral ventral …
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) [Phase 3]
Phase 3 trial evaluating dutasteride 0.5 mg for Chinese patients with benign prostatic hyperplasia completed with results posted.
-
FDA approval · 2010-03-02FDA Approved: TAMSULOSIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approves the Original Application for Tamsulosin Hydrochloride from Amneal Pharmaceuticals of New York LLC, a generic drug for benign pr…
-
FDA approval · 2010-02-23FDA Approved: FINASTERIDE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare's generic finasteride through an Original Application for the treatment of benign prostatic hyperplasia and a…
-
CLINICAL_TRIALS trial_result · 2010-02-04Clinical Trial Update: Temperature Mapping of the Prostate With the Wallterm™ System
Clinical trial update reporting temperature mapping of the prostate using the Wallterm system in men with Benign Prostatic Hyperplasia; the …
-
FDA approval · 2010-02-01FDA Approved: CIALIS — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cialis (tadalafil) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2010-01-21Clinical Trial Update: Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy [Phase 2]
Phase 2 trial evaluating vardenafil in conjunction with GreenLight laser surgery for benign prostatic hyperplasia has completed and posted r…
-
FDA approval · 2010-01-14FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for doxazosin submitted by Mylan Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2010-01-14Clinical Trial Update: Minimally Invasive Surgical Therapy for BPH [Phase 3]
A Phase 3 clinical trial of Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia sponsored by NIDDK has been terminated.